Can Chen is working for IMS Health, Asia Pacific, Singapore. One of his research papers are Cost-minimization Analysis between Sevelamer and Lanthanum in Treating Hyperphosphatemia among Patients with End-stage Renal Disease in China. His research interest includes Hyperphosphatemia, Disease burden, Sevelamer, Cost-minimization.